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Purpose: Prostate biopsy for diagnosing cancer can be painful. The efficacy and safety 
of combination perianal-intrarectal lidocaine-prilocaine (PILP) cream and peripro-
static nerve block were compared with nerve block alone during transrectal ultrasound 
guided prostate biopsy (TRUS-Bx).
Materials and Methods: From October 2007 to August 2009, 74 men undergoing a trans-
rectal prostate biopsy were randomized into two groups. In group 1, 36 patients received 
a combination of PILP cream and a periprostatic nerve block; and in group 2, 38 patients 
received lubricant jelly and a periprostatic nerve block. Thirty minutes later, the 
TRUS-Bx was performed. Pain was evaluated by a 10-point visual analogue scale (VAS) 
after the biopsy.
Results: Patients in group 1 showed a significantly lower VAS score than patients in 
group 2 (mean score 2.22±0.89 vs. 3.02±1.15, p＜0.001). In addition, there was a differ-
ence in the number of patients that had a pain score of three or more, 44% in group 1, 
and 65% in group 2. The overall complication rate was similar in both groups (p=0.45).
Conclusions: A combination of PILP cream and periprostatic nerve block reduced pain 
compared to the periprostatic nerve block alone. This safe, simple technique can be con-
sidered prior to TRUS-Bx to reduce patient discomfort.
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INTRODUCTION
Transrectal ultrasound guided prostate biopsy (TRUS-Bx) 
is a standard procedure used for prostate cancer detection. 
However, it has recently been reported that most of the pa-
tients that undergo TRUS-Bx tolerated the associated dis-
comfort, and 20% of these patients experienced severe pain 
[1-3]. 
　Therefore, researchers have tried to reduce the pain as-
sociated with the TRUS-Bx. If the procedure-associated 
pain could be reduced, this may improve patient compli-
ance. The two main causes of the pain during the biopsy are 
the transducer inserted into the rectum, and the biopsy 
needle that advances through the prostate capsule. To de-
crease the associated pain, several anesthetic methods in-
cluding analgesics, topical applications, and nerve blocks 
have been used. Among these methods, the peri-prostatic 
nerve block (PPNB) provides very effective pain control 
[4,5]. 
　However, this does not control the pain associated with 
the transducer being inserted into the anus. Therefore, in 
an effort to decrease the pain from the insertion, several 
studies have shown the efficacy of applying lidocaine-prilo-
caine cream or lidocaine jelly along with PPNB. However, 
no prior study on the application of lidocaine-prilocaine 
cream with PPNB has been carried out in Korea. Therefore, Korean J Urol 2010;51:463-466
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TABLE 1. Characteristics and VAS results of patients who 
underwent prostate biopsy
PILP＋NB NB only p-value
No. of patients
Age (years)
PSA (ng/ml)
Prostate volume (ml)
Pain score
Complication rate (%)
36
65.4±7.3
16.3±28.2
32.4±13.1
2.22±0.89
50
38
64.1±11.1
10.6±12.8
33.6±16.0
3.02±1.15
53
0.569
a
0.261
a
0.723
a
0.001
a
0.45
b
PSA: prostate-specific antigen, VAS: visual analogue scale, PILP:
perianal-intrarectal lidocaine-prilocaine, NB: nerve block, 
a: com-
parison between PILP＋NB and NB only groups using the 
Student’s t-test, 
b: comparison between PILP＋NB and NB only
groups using the Pearson chi-square test
FIG. 1. Individual pain assessment, gray (PILP＋NB), black (NB
only). Data are shown as the percent or number of patients with 
each pain score according to visual analogue scale. PILP: 
perianal-intrarectal lidocaine-prilocaine, NB: nerve block.
the effects on pain control of perianal-intrarectal lidocaine- 
prilocaine (PILP) cream applied to the anus and rectum in 
addition to PPNB  were evaluated in this study.
MATERIALS AND METHODS
From October 2007 to August 2009, a prospective, random-
ized, placebo-controlled study was performed. Patients 
that satisfied the inclusion criteria were enrolled including 
patients with any of the following: 1) increased prostate- 
specific antigen (PSA) with or without an abnormal digital 
rectal examination (DRE); 2) lesions suspicious for a malig-
nancy on the TRUS with or without an abnormal DRE; or 
3) an abnormal DRE finding. 
　Patients were excluded if they had a history of a previous 
prostate biopsy, had chronic prostatalgia, anal diseases 
such as an anal fissure, hemorrhoids, anal surgery, chronic 
prostatitis/pelvic pain syndrome, concomitant analgesic 
medication, any other medical condition that could poten-
tially interfere with pain assessment, a history of warfarin 
treatment or a bleeding tendency, or impaired intellectual 
ability.
　A total of 74 men who met the criteria and agreed to par-
ticipate in the study were enrolled after providing written 
consent. They were then randomized by a coin toss to un-
dergo TRUS-Bx with combined anesthesia (PILP cream 
and PPNB) (group 1), or PPNB only (lubricant jelly and 
PPNB) (group 2). A urologist administered the PILP cream 
(5 ml, 5 g) or inert lubricant gel intrarectally with a syringe 
and massaged it into the anterior rectal wall anal canal and 
perianal skin. Patients were informed that they had re-
ceived a dose of a topical substance but they were blinded 
to the randomization results. Thirty minutes after the ap-
plication the prostate TRUS-Bx was performed. 
　For the nerve block technique, the patients received 10 
cc of 1% lidocaine local injections into both sides of the pros-
tate’s lateral posterior area guided by a transrectal ultra-
sound. A Philips IU-22 transducer (Philips, Bothell, WA, 
USA) with a 9.5 MHz rectal probe was used for images in 
the transaxial and sagittal planes. In most patients, 12 core 
prostate biopsies were performed, including six para-
sagittal and six laterally targeted biopsies covering the 
base, mid zones, and apexes, using a spring-loaded biopsy 
gun and an 18 gauge AceCut biopsy needle (TSK Labora-
tory, Tochigi, Japan). 
　Three hours after the biopsy, another urologist who had 
no information about the two groups asked the patients 
about the pain during the TRUS-Bx. The scale was a linear, 
10-point visual analog scale of 0 to 10 cm with pain/dis-
comfort, scored as 0: no pain, 1 to 3: mild, 4 to 6: moderate, 
7 to 9: severe and 10: unbearable pain.     
　All patients were discharged the next day after ob-
servation for complications such as gross hematuria, rectal 
bleeding, voiding difficulty, or fever. A week after dis-
charge, the patients were assessed for the results of the bi-
opsy and other possible side effects. 
　Differences in the age, PSA levels, volume of the prostate, 
VAS scores, and complications were compared between the 
two treatment and control groups. The difference in pain 
between the two groups and other variables were analyzed 
by the Student’s t-test. In addition, Pearson’s chi-square 
test was used to compare frequency and complications. The 
p-value was accepted as significant when it was less than 
0.05. All analysis was performed using SPSS
Ⓡ ver. 16.0 
(SPSS Inc., Chicago, IL, USA).
RESULTS
Among the 74 patients, 36 in group 1 and 38 in group 2, 12 
core prostate biopsies were obtained, and they were en-
rolled in the study for data analysis. The mean patient age, 
serum PSA, and total prostate volume were similar in the 
two groups (Table 1). Twenty six patients (35%) were diag-
nosed with prostate cancer; 13 patients were assigned to 
group 1 (36%), and 13 to group 2 (34%). There was no sig-
nificant difference in cancer prevalence between the two 
groups. 
　Table 1 and Fig. 1 show the VAS scores obtained in the Korean J Urol 2010;51:463-466
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FIG. 2. Comparison in the percent of patients with pain score of
≥3 or ＜3 between PILP＋NB and NB only groups. Data are 
shown as the percent of patients and the comparison between 
the two is performed using the Pearson chi-square test. PILP: 
perianal-intrarectal lidocaine-prilocaine, NB: nerve block.
two groups. The mean VAS score in patients with PILP 
cream application prior to the PPNB was lower than that 
of the patients that did not receive the cream application 
prior to the PPNB (2.2 vs. 3.0, p=0.001). 
　In addition, there was a difference in the number of pa-
tients that had a pain score of three or more: 44% in group 
1 and 65% in group 2 (Fig. 1, 2). 
　No general or local adverse effects were associated with 
the anesthetic. There were only minor complications, such 
as mild hematuria, mild hematochezia and hemospermia. 
Thirty-three patients had gross hematuria, three patients 
had hematochezia, and one patient had acute urinary 
retention. All patients recovered with conservative man-
agement; no patient required hospitalization due to com-
plications including sepsis. There were no differences in 
the complication rates between the two groups. 
DISCUSSION
Although the TRUS-Bx is a standard procedure for pros-
tate cancer detection, TURS-Bx related pain or discomfort 
has been reported during the procedure associated with the 
anorectal probe and puncture of the prostate capsule. 
Zisman et al. evaluated the impact of a prostate biopsy on 
211 men and reported that immediate pain or discomfort 
was reported in 96% and 89% of their patients, respectively 
[6]. 
　Pain during the TRUS-Bx can be attributed to two main 
factors: anal discomfort due to the ultrasound probe passed 
into the rectum and the insertion of needles through the 
prostate gland. Mostly, the prostate biopsy-related pain is 
caused by the needle penetrating the prostate capsule. This 
penetration results in periprostatic nerve stimulation of 
sensory receptors located in the capsule. PPNB is, there-
fore, a good choice to control this pain. This method has 
been clinically applied since 1996 when it was first reported 
by Nash et al, who suggested that bilateral injections at the 
junction of the base of the prostate and seminal vesicles pro-
vided good pain control [7]. Their positive findings were 
subsequently confirmed by Pareek et al and Leibovici et al 
[4,8]. Now, periprostatic nerve block with 1% lidocaine is 
considered the gold standard for analgesic anesthesia be-
fore performing an office-based prostate biopsy.  
　However, control of anal discomfort has not been 
adequate. The rectum is innervated below the dentate line 
by the inferior rectal branches of the pudendal nerve. 
Therefore, another method of pain control is needed for the 
anal pain. 
　There are many studies on the efficacy of local anesthetic 
agents such as lidocaine cream or jelly application. 
Kandirali et al reported that only perianal anesthesia with 
lidocaine-prilocaine cream was sufficient to decrease the 
pain during a TRUS-Bx [9]. Stirling et al reported that the 
postprocedural pain scores were significantly lower in the 
group that received 10 ml of 2% lidocaine gel intrarectally 
compared to the group that received no anesthetic; in addi-
tion, the postprocedural scores for probe insertion were sig-
nificantly lower in the topical group than in the control 
group [10].  
　However, other studies did not confirm the efficacy of in-
trarectal lidocaine, and in some studies inferior results 
were obtained compared to the PPNB [11-16]. 
　Now lidocaine gel or cream is used in combination with 
PPNB rather than either method alone. Giannarini et al 
reported that the combination of PILP cream and peripro-
static nerve block provides better pain control than the 
cream or the PPNB alone [17].
　In Korea, one study has investigated the efficacy of a com-
bination of intrarectal lidocaine gel with PPNB [18]. This 
study showed that the combination of intrarectal lidocaine 
gel and periprostatic nerve block was effective in reducing 
pain during repeat prostate biopsies and the pain felt dur-
ing transrectal probe insertion. 
　These findings are consistent with the findings of this 
study. A combination of PILP cream and periprostatic 
nerve block showed less pain than the periprostatic nerve 
block alone (2.22±0.89 vs. 3.02±1.15). Pain was assessed 
in a prospective fashion. The pain score was recorded three 
hours after the TRUS-Bx. Thus, recall bias was not an 
issue. The results of this study suggest that the combina-
tion of PILP cream and periprostatic nerve block was an 
effective and useful technique and well tolerated by 
patients.
　PILP cream was chosen as the topical anesthesia be-
cause, in addition to its established efficacy and rapid ab-
sorption, it has been shown to have no side effects in prior 
studies [19,20]. In this study, there were no side effects as-
sociated with the PILP cream and patient compliance was 
good. No significant morbidity was noted in either study 
group. Rectal bleeding, hematuria, and hemospermia were 
self-limited and did not result in hospitalization or the need 
for additional treatment. 
　Lidocaine-prilocaine cream is available at most TRUS- Korean J Urol 2010;51:463-466
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Bx centers, and its use for prostate biopsy procedures is safe 
and easy. Except for the rare patient with allergies to local 
anesthesia, PILP cream prior to PPNB should be consid-
ered in all men undergoing TRUS-Bx.  
　The limitations of this study include the following. The 
study had a small number of patients and there was little 
difference among the pain scores. After the findings 
showed less pain in the combination group, PILP cream 
was applied in all patients undergoing TRUS-Bx. Thus, we 
could no longer recruit patients. 
　However, to our knowledge, this is the first domestic re-
port on the combined effect of lidocaine-prilocaine cream 
with PPNB on pain control during TRUS-Bx. The numer-
ical difference in the pain score was small but statistically 
meaningful. Prior studies have shown similar pain scores 
and differences between anesthetic methods [17,18]. 
Moreover, a difference was also found in the number of pa-
tients with three or more on the pain score, 44% in group 
1, and 65% in group 2. The frequency of moderate to severe 
pain was significantly lower in the combination group.
CONCLUSIONS
A combination of lidocaine-prilocaine cream and a peripro-
static nerve block was safe and effective for pain control in 
patients undergoing TURS-Bx. A periprostatic nerve block 
plus lidocaine-prilocaine cream can be considered for pa-
tients undergoing TURS-Bx.
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